Trial Profile
Study of the improvement effect of the Maintenance treatment of Vonoprazan and Esomeprazole on symptoms in patients with gastro-esophageal reflux disease (GERD)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2018
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 15 May 2018 New trial record